Although studies of METTL1 have been limited, overexpression of METTL1 could drive tumor progression which was reported in hepatocellular carcinoma, colon cancer, intrahepatic cholangiocarcinoma, and lung cancer (9–13). The gene discussed is METTL1; the disease is lung carcinoma.